AMSTERDAM (AP) — AMSTERDAM (AP) — UniQure NV (QURE) on Thursday reported a loss of $56.3 million in its second quarter.
On a per-share basis, the Amsterdam-based company said it had a loss of $1.16.
The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $1.24 per share.
The human gene therapy company posted revenue of $11.1 million in the period, also surpassing Street forecasts. Three analysts surveyed by Zacks expected $3.5 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on QURE at https://www.zacks.com/ap/QURE
